Wockhardt Ltd Quarterly Results
Q2 FY26-27 Results Summary
Revenue
The revenue stands at ₹969.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.31 per cent from ₹929.00 crore. This corresponds to a year-on-year *(YoY) growth of 23.91 per cent.
Operating Profit
Operating Profit stands at ₹173.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 9.90 per cent from ₹192.00 crore. This corresponds to a year-on-year *(YoY) decline of 2.81 per cent.
PBDT
PBDT stands at ₹128.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 25.15 per cent from ₹171.00 crore. This corresponds to a year-on-year *(YoY) decline of 11.11 per cent.
Profit Before Tax
Profit Before Tax stands at ₹73.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 37.07 per cent from ₹116.00 crore. This corresponds to a year-on-year *(YoY) decline of 19.78 per cent.
Net Profit
Net Profit stands at ₹73.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 31.78 per cent from ₹107.00 crore. This represents a 10.98 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Wockhardt Ltd News
Wockhardt Ltd Earnings
- YOY
- QOQ
Wockhardt Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Wockhardt Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Wockhardt Ltd Financial Reports
Wockhardt Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Wockhardt | -1.86% | 3.16% | -3.89% | 1.00% | 21.48% | 43.42% |
| Ajanta Pharma | 0.84% | -2.57% | -3.78% | -5.77% | 9.08% | 30.85% |
| Sai Life | 11.83% | 15.94% | 18.53% | 25.31% | 59.82% | 96.82% |
| Piramal Pharma | 0.17% | -0.21% | 21.76% | 11.96% | 33.07% | 22.42% |
| Acutaas Chemical | 0.52% | -2.59% | 23.80% | 15.35% | 38.52% | 114.29% |
| Rubicon Research | -4.50% | -0.46% | 8.37% | 4.15% | 74.09% | 166.92% |
| Neuland Labs. | -0.22% | 0.92% | -5.99% | -10.98% | 11.66% | 9.10% |
Company Info
Company Information
Chairman & Exec. Director : H F Khorakiwala
Independent Non Exe. Director : Vineshkumar Jairath
Independent Non Exe. Director : Akhilesh Krishna Gupta
Independent Non Exe. Director : Amelia Fernandes
Independent Non Exe. Director : Ahmad Javed
Independent Non Exe. Director : O P Bhatt
Executive Director : Huzaifa H Khorakiwala
Executive Director & MD : Murtaza H Khorakiwala
Non-Exec & Non-Independent Dir : Zahabiya Habil Khorakiwala
Company Sec. & Compli. Officer : Rashmi Mamtura